A Win For Corbus Pharmaceuticals Holdings, Inc.
Tue, Mar 14, 2023 at 07:09 PM
Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ) jumped higher at $3.07, a gain of 36.4%. On Tue, Mar 14, 2023, CRBP:NASDAQ hit a New 2-Week High of $3.07. The stock got featured on our News Catalysts scanner on Tue, Mar 14, 2023 at 05:05 PM in the 'BIOTECH' category. From Tue, Feb 28, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Nov 30, 2022 at $6.78 with a volume of 3M+.
About Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ)
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company. Its business involves the development of therapeutics to address serious inflammatory diseases such as cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis.
Top 10 Gainers:
- Ambipar Emergency Response Class A (AMBI:NYSEMKT), 116.81%
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 64.84%
- Rubicon Technologies Inc. Class A (RBT:NYSE), 54.17%
- Metropolitan Bank Holding Corp. (MCB:NYSE), 38.98%
- Mmtec, Inc. (MTC:NASDAQ), 38.93%
- Lavoro Limited (LVRO:NASDAQ), 37.77%
- SOPHiA GENETICS SA (SOPH:NASDAQ), 37.47%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 36.44%
- Avid Bioservices, Inc. (CDMO:NASDAQ), 35.96%
- PacWest Bancorp (PACW:NASDAQ), 33.85%